NASDAQ:AIKI AIkido Pharma (AIKI) Stock Price, News & Analysis $2.53 +0.08 (+3.27%) As of 09/21/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsSEC Filings About AIkido Pharma Stock (NASDAQ:AIKI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get AIkido Pharma alerts:Sign Up Key Stats Today's Range$2.41▼$2.6950-Day Range$1.94▼$3.1452-Week Range$3.31▼$11.48Volume500,206 shsAverage Volume79,326 shsMarket Capitalization$13.88 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview AIkido Pharma Inc. (NASDAQ: AIKI) is a biotechnology and life sciences company focused on identifying, acquiring and developing therapeutic technologies. Its activities have included the development of potential treatments for cancer and other serious diseases, as well as the evaluation of early-stage pharmaceutical assets and intellectual property. The company has historically pursued a portfolio-based strategy, seeking licensing opportunities, research collaborations and investments in emerging technologies rather than operating as a large commercial pharmaceutical manufacturer. Its work has included investigating novel drug candidates and partnering with academic and industry researchers to advance preclinical programs. AIkido Pharma was previously known as Spherix Incorporated before adopting its current name. Publicly available information about its active product pipeline, commercial operations, geographic reach and current leadership is limited, and the company’s programs remain primarily associated with early-stage biotechnology development.AI Generated. May Contain Errors. Read More Receive AIKI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIKI Stock News HeadlinesAIkido Pharma Inc. Common Stock (AIKI)July 29, 2026 | nasdaq.comCrypto, Real Estate, And More: The Lesser-Known 'Dealmakers' Behind Trump’s $5 Billion EmpireAugust 20, 2025 | msn.comPass by August 7… or wait until 2027?Last month I told investors that a Trump-backed crypto bank could be approved any day. On August 14, it was. Federal regulators granted conditional approval to World Liberty Trust Company… a nationally chartered trust bank tied to the Trump family's crypto venture. Most investors still haven't processed what that means. This bank exists to do one thing. Issue, redeem, custody and back USD1… the stablecoin that has now crossed $4 billion in circulation. The bank isn't operating yet. There are conditions to satisfy first… capital minimums, an audit manager, a sign-off on the business plan. Which means the money hasn't moved yet.September 22 at 1:00 AM | Crypto 101 Media (Ad)How an Obscure Firm Bet on the Trumps and Became Their Go-To DealmakerAugust 19, 2025 | msn.comDon Jr. And Eric Trump Could Soon Sell $9.6 Million In Stock Granted For Brief Advisory Board Tenure, SEC Filing RevealsApril 26, 2025 | msn.comDon Jr. And Eric Trump Landed $3 Million In Stock For Joining Firm’s Advisory Board That Had Little Public Presence Before Their AppointmentApril 17, 2025 | msn.comTrump Sons Joined Dominari Holding’s Advisory Board–But There’s Little Public Record The Board Existed BeforehandMarch 7, 2025 | forbes.comDon Jr. and Eric Trump invest in small biotech turned fintech based in Trump Tower, sending stock skywardFebruary 12, 2025 | msn.comSee More Headlines AIKI Stock Analysis - Frequently Asked Questions How have AIKI shares performed this year? AIkido Pharma's stock was trading at $4.95 on January 1st, 2026. Since then, AIKI stock has decreased by 48.9% and is now trading at $2.53. When did AIkido Pharma's stock split? AIkido Pharma's stock reverse split on Tuesday, June 7th 2022.The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. Does AIkido Pharma have any subsidiaries? The following companies are subsidiaries of AIkido Pharma: Hoth Therapeutics. How do I buy shares of AIkido Pharma? Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AIkido Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that AIkido Pharma investors own include Atossa Genetics (ATOS), Bionano Genomics (BNGO), Ocugen (OCGN), Meta Platforms (META), Cineverse (CNVS) and Company Calendar Today9/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Capital Markets Sub-IndustryInvestment Banking & Brokerage Current SymbolNASDAQ:AIKI CIK12239 Webwww.spherix.com Phone(112) 745-1374Fax703-992-9348Employees4Year Founded1967Profitability EPS (Trailing Twelve Months)($3.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.17 million Net MarginsN/A Pretax MarginN/A Return on Equity-18.21% Return on Assets-16.94% Debt Debt-to-Equity RatioN/A Current Ratio29.54 Quick Ratio29.54 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$19.27 per share Price / Book0.13Miscellaneous Outstanding Shares5,485,000Free Float5,013,000Market Cap$13.88 million OptionableNot Optionable Beta0.93 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:AIKI) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersThe drone firm the Pentagon chose for next-gen defenseOne Nasdaq-listed drone company already supplies the US Army, Air Force, and Navy with mission-ready drone sys...Tomorrow Investor | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredChina's dominance in rare earth processing sparks new defense rulesOn January 1, 2027, new Pentagon rules tighten sourcing restrictions on critical minerals tied to foreign adve...The Tomorrow Investor | Sponsored“Elon Is Not Showing This Publicly, But I Saw It”Elon Musk quietly filed a patent for a new AI invention while attention focused on the SpaceX IPO. Jeff Brown,...Brownstone Research | SponsoredPass by August 7… or wait until 2027?Last month I told investors that a Trump-backed crypto bank could be approved any day. On August 14, it was...Crypto 101 Media | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
